ASND - Ascendis Pharma A/S - ADR
IEX Last Trade
138.605
0.665 0.480%
Share volume: 222,669
Last Updated: Fri 30 Aug 2024 09:59:34 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$137.94
0.67
0.48%
Summary score
9%
Profitability
0%
Dept financing
3%
Liquidity
50%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-13.37%
Return on assets
-12.12%
Return on sales
0%
Return on invested capital
-63.51%
Total debt ratio
10.35%
Debt ratio change over timeo
-0.98%
Current Ratio
11.91%
Quick Ratio
0%
Cash Position Ratio
11.35%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-12.06%
Return on assets
-10.82%
Return on sales
0%
Return on invested capital
-356.83%
Total debt ratio
12.1%
Debt ratio change over timeo
-1.05%
Current Ratio
12.68%
Quick Ratio
0%
Cash Position Ratio
11.29%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-19.51%
Return on assets
-14.51%
Return on sales
0%
Return on invested capital
-636.98%
Total debt ratio
14.89%
Debt ratio change over time
-1.07%
Current Ratio
9.04%
Quick Ratio
0%
Cash Position Ratio
4.43%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-103.21%
Return on assets
-103.15%
Return on sales
0%
Return on invested capital
35.69%
Total debt ratio
-98.16%
Debt ratio change over time
-0.98%
Current Ratio
1.54%
Quick Ratio
0%
Cash Position Ratio
1.54%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ASND | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -13.37% | -3.05% | 11.55% | 6.27% |
| Return on assets | -12.12% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | -63.51% | 5.09% | 7.99% | 13.19% |
| Profitability | 0% | 46% | 82% | 83% |
| Total debt ratio | 10.35% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.98% | 6.09% | 6.03% | 1.53% |
| Dept financing | 3% | 50% | 43% | 14% |
| Current Ratio | 12.68% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 11.29% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 15% | 34% | 33% |
| Short-term ratios | ASND | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -12.06% | -25.62% | 17.94% | 7.14% |
| Return on assets | -10.82% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | -356.83% | 8.14% | 7.17% | 18.16% |
| Profitability | 0% | 49% | 79% | 82% |
| Total debt ratio | 12.1% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -1.05% | -23.44% | 9.66% | 0.6% |
| Dept financing | 3% | 25% | 45% | 8% |
| Current Ratio | 12.68% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 11.29% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 25% | 21% | 35% |